Skip to content

Prediction of Early Recovery of Liver Function After LDLT in Children: An Ambispective Cohort Study

Prediction of Early Recovery of Liver Function After Living Donor Liver Transplantation in Children: An Ambispective Cohort Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06045949
Enrollment
230
Registered
2023-09-21
Start date
2022-07-31
Completion date
2023-09-01
Last updated
2023-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver and Biliary Tract Disorders in Duration of Pregnancy, Other End-stage Liver Diseases in Children

Brief summary

The investigators included children with living donor liver transplantation (LDLT) from January 1, 2018 to July 31, 2022 as a retrospective cohort, and the group from August 1, 2022 to June 30, 2023 as a prospective cohort. The investigators collected the demographic and clinicopathological data of donors and recipients, and determined the risk factors of early postoperative delayed recovery of hepatic function (DRHF) by univariate and multivariate Logical regression analyses.

Interventions

None listed

Sponsors

Huiwu Xing
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
0 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

1. children with the indication of LDLT \[cholestatic liver disease (such as BA), metabolic liver disease (such as Wilson's disease and Ornithine transcarbamylase deficiency), acute liver failure (such as drug induced), neoplastic disease (such as hepatoblastoma), vascular disease (such as cavernous transformation of portal vein and congenital absence of portal vein), re-transplantation and others\]; 2. the relatives of the children voluntarily donated part of the liver which met the requirements of LDLT.

Exclusion criteria

1. recipients with contraindications of LDLT (such as coagulation dysfunction, acute infection, cardiopulmonary failure); 2. failure to complete LDLT due to various reasons (such as death during or within 3 days after operation); 3. recipients or donors with incomplete necessary data.

Design outcomes

Primary

MeasureTime frameDescription
DRHF30 days after LDLT in childrenInvestigators collected liver function data of children after LDLT. Delayed recovery of hepatic function (DRHF) is characterized by the increase of PT-INR combined with hyperbilirubinemia on or after postoperative day 5.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026